• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者:他们最希望改善哪些症状,以及随着疾病持续时间的变化,这种情况会如何变化?

People with Parkinson's Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?

机构信息

Parkinson's UK, London, UK.

Research Support Network, London, UK.

出版信息

J Parkinsons Dis. 2021;11(2):715-724. doi: 10.3233/JPD-202346.

DOI:10.3233/JPD-202346
PMID:33459664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8150663/
Abstract

BACKGROUND

Parkinson's disease (PD) is a neurodegenerative condition with a diverse and complex pattern of motor and non-motor symptoms which change over time with disease duration.

OBJECTIVE

The aims of the present study were to discover what symptoms matter most to people with the condition and to examine how these priorities change with disease duration.

METHODS

A simple free-text online survey (using SmartSurvey) was developed by Parkinson's UK, which asked participants to identify up to three aspects of the condition they would most like to see improvement in.

RESULTS

790 people participated reporting 2,295 issues related to PD which were grouped into 24 broad symptom domains. Of these, 1,358 (59.1%) were categorised as motor symptoms, 859 (37.4%) as non-motor issues and 78 (3.4%) as medication problems. This study reveals how certain features of PD become more or less important to patients as the condition progresses. Non-motor symptoms were highly cited from the very earliest stages of PD. Problems with walking, balance and falls, speech problems, freezing and dyskinesia become increasingly important as the condition progresses whereas tremor, stiffness and psychological health become decreasingly important as the condition progresses.

CONCLUSIONS

The data suggest that the priorities of people affected by PD for improving life are personal and change with duration of the condition. These findings have implications for developing person-centred management and care, as well as for directing future research to improve quality of life.

摘要

背景

帕金森病(PD)是一种神经退行性疾病,其运动和非运动症状具有多样化且复杂的模式,且随着疾病的进展而随时间变化。

目的

本研究旨在发现对患有该疾病的人最重要的症状,并研究这些优先级如何随疾病的进展而变化。

方法

帕金森病英国协会(Parkinson's UK)开发了一个简单的在线自由文本调查(使用 SmartSurvey),要求参与者最多选择三个他们希望看到改善的疾病方面。

结果

790 人参与了研究,报告了与 PD 相关的 2295 个问题,这些问题被分为 24 个广泛的症状领域。其中,1358 个(59.1%)被归类为运动症状,859 个(37.4%)为非运动问题,78 个(3.4%)为药物问题。本研究揭示了随着疾病的进展,某些 PD 特征对患者的重要性如何变化。非运动症状在 PD 的早期阶段就被高度引用。随着疾病的进展,行走、平衡和跌倒、言语问题、冻结和运动障碍等问题变得越来越重要,而震颤、僵硬和心理健康等问题变得越来越不重要。

结论

这些数据表明,受 PD 影响的人的生活改善重点是个人的,且随着疾病的进展而变化。这些发现对开发以患者为中心的管理和护理具有影响,也为指导未来改善生活质量的研究提供了方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/8df120f39193/jpd-11-jpd202346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/3c6a1887edf5/jpd-11-jpd202346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/36006b6208bc/jpd-11-jpd202346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/329c5a52c81c/jpd-11-jpd202346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/8df120f39193/jpd-11-jpd202346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/3c6a1887edf5/jpd-11-jpd202346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/36006b6208bc/jpd-11-jpd202346-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/329c5a52c81c/jpd-11-jpd202346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/8150663/8df120f39193/jpd-11-jpd202346-g002.jpg

相似文献

1
People with Parkinson's Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?帕金森病患者:他们最希望改善哪些症状,以及随着疾病持续时间的变化,这种情况会如何变化?
J Parkinsons Dis. 2021;11(2):715-724. doi: 10.3233/JPD-202346.
2
Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease.确定帕金森病管理十大研究重点的优先事项设定伙伴关系。
BMJ Open. 2014 Dec 14;4(12):e006434. doi: 10.1136/bmjopen-2014-006434.
3
Self-Reported Symptoms of Parkinson's Disease by Sex and Disease Duration.按性别和病程自我报告的帕金森病症状
West J Nurs Res. 2017 Nov;39(11):1412-1428. doi: 10.1177/0193945916670904. Epub 2016 Sep 23.
4
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.帕金森病多模态综合治疗改善运动症状、抑郁和生活质量。
J Neurol. 2020 Apr;267(4):954-965. doi: 10.1007/s00415-019-09657-7. Epub 2019 Dec 3.
5
Understanding what aspects of Parkinson's disease matter most to patients and families.了解帕金森病的哪些方面对患者和家属最重要。
Sci Rep. 2024 Sep 11;14(1):21171. doi: 10.1038/s41598-024-71555-4.
6
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.五个欧洲国家中存在运动波动和异动症的帕金森病患者的生活质量
Parkinsonism Relat Disord. 2014 Sep;20(9):969-74. doi: 10.1016/j.parkreldis.2014.06.001. Epub 2014 Jun 10.
7
Clinical Evaluation in Parkinson's Disease: Is the Golden Standard Shiny Enough?帕金森病的临床评估:金标准是否足够闪亮?
Sensors (Basel). 2023 Apr 7;23(8):3807. doi: 10.3390/s23083807.
8
Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.基于运动和策略的物理治疗干预预防帕金森病患者反复跌倒:PDSAFE RCT。
Health Technol Assess. 2019 Jul;23(36):1-150. doi: 10.3310/hta23360.
9
Analyzing the effects of PDSAFEx™ on the motor symptoms of Parkinson's disease: A retrospective study.分析PDSAFEx™对帕金森病运动症状的影响:一项回顾性研究。
NeuroRehabilitation. 2020;46(4):589-593. doi: 10.3233/NRE-203025.
10
Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.前驱期帕金森病中非运动症状的患病率和持续时间。
Eur J Neurol. 2019 Jul;26(7):979-985. doi: 10.1111/ene.13919. Epub 2019 Mar 1.

引用本文的文献

1
A personalised, gait training telerehabilitation programme for people with Parkinson's Disease: A long-term pilot study.一项针对帕金森病患者的个性化步态训练远程康复计划:一项长期试点研究。
Clin Rehabil. 2025 Aug;39(8):1034-1047. doi: 10.1177/02692155251355880. Epub 2025 Jul 14.
2
Using machine learning to identify Parkinson's disease severity subtypes with multimodal data.利用机器学习通过多模态数据识别帕金森病严重程度亚型。
J Neuroeng Rehabil. 2025 Jun 2;22(1):126. doi: 10.1186/s12984-025-01648-2.
3
Aquatic Therapy Versus Land-Based Therapy in Patients with Parkinson's Disease: A Systematic Review.

本文引用的文献

1
Patient and physician perceptions of disease management in Parkinson's disease: results from a US-based multicenter survey.帕金森病患者及医生对疾病管理的认知:一项基于美国的多中心调查结果
Neuropsychiatr Dis Treat. 2019 May 30;15:1487-1495. doi: 10.2147/NDT.S196930. eCollection 2019.
2
Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.开发和验证帕金森病亚型及其运动和认知进展。
J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1279-1287. doi: 10.1136/jnnp-2018-318337. Epub 2018 Jul 25.
3
Fatigue in Parkinson's disease: A systematic review and meta-analysis.
帕金森病患者的水疗与陆地疗法:一项系统评价
J Funct Morphol Kinesiol. 2025 May 12;10(2):170. doi: 10.3390/jfmk10020170.
4
Amplifying walking activity in Parkinson's disease through autonomous music-based rhythmic auditory stimulation: randomized controlled trial.通过基于音乐的自主节奏听觉刺激增强帕金森病患者的步行活动:随机对照试验
NPJ Parkinsons Dis. 2025 Apr 29;11(1):100. doi: 10.1038/s41531-025-00952-x.
5
Factors Associated With the Decline in Daytime Bed Mobility Independence in Patients With Parkinson's Disease: A Cross-Sectional Study.帕金森病患者日间床上活动独立性下降的相关因素:一项横断面研究。
J Mov Disord. 2025 Jul;18(3):231-243. doi: 10.14802/jmd.25035. Epub 2025 Apr 25.
6
A fragment of Calpain-1 cleaved α-Synuclein quantified in serum is upregulated in patients with Parkinson's disease.在血清中定量的钙蛋白酶-1切割的α-突触核蛋白片段在帕金森病患者中上调。
Sci Rep. 2025 Apr 9;15(1):12081. doi: 10.1038/s41598-025-92726-x.
7
Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson's Disease.帕金森病早期有意义症状及功能影响的系统评价与共识概念模型
NPJ Parkinsons Dis. 2025 Apr 3;11(1):65. doi: 10.1038/s41531-025-00907-2.
8
What are the Key Challenges Faced by Spinocerebellar Degeneration and Multiple System Atrophy Patients in Daily Life?: Insights from a Comprehensive Questionnaire Survey in Japan.脊髓小脑变性症和多系统萎缩症患者在日常生活中面临的关键挑战有哪些?来自日本一项综合问卷调查的见解。
Cerebellum. 2025 Apr 1;24(3):78. doi: 10.1007/s12311-025-01831-0.
9
Psychological stress associated with prognostic uncertainties in recently diagnosed Parkinson's disease patients: A qualitative study.近期诊断的帕金森病患者预后不确定性相关的心理压力:一项定性研究。
PLoS One. 2025 Mar 11;20(3):e0319576. doi: 10.1371/journal.pone.0319576. eCollection 2025.
10
Passive Monitoring of Parkinson Tremor in Daily Life: A Prototypical Network Approach.帕金森震颤在日常生活中的被动监测:一种典型的网络方法。
Sensors (Basel). 2025 Jan 9;25(2):366. doi: 10.3390/s25020366.
帕金森病疲劳:系统评价和荟萃分析。
Mov Disord. 2018 Nov;33(11):1712-1723. doi: 10.1002/mds.27461. Epub 2018 Sep 28.
4
Impact of Tremor on Patients With Early Stage Parkinson's Disease.震颤对早期帕金森病患者的影响。
Front Neurol. 2018 Aug 3;9:628. doi: 10.3389/fneur.2018.00628. eCollection 2018.
5
The clinical heterogeneity of Parkinson's disease and its therapeutic implications.帕金森病的临床异质性及其治疗意义。
Eur J Neurosci. 2019 Feb;49(3):328-338. doi: 10.1111/ejn.14094. Epub 2018 Oct 14.
6
Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.帕金森病的共病与多重用药:来自苏格兰大型初级保健数据库的见解
BMC Neurol. 2017 Jul 1;17(1):126. doi: 10.1186/s12883-017-0904-4.
7
A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.2005 年至 2015 年帕金森病睡眠和觉醒障碍文献的系统回顾。
Sleep Med Rev. 2017 Oct;35:33-50. doi: 10.1016/j.smrv.2016.08.001. Epub 2016 Aug 31.
8
Challenges of Improving Patient-Centred Care in Parkinson's Disease.改善帕金森病以患者为中心的护理面临的挑战。
J Parkinsons Dis. 2017;7(1):163-174. doi: 10.3233/JPD-160922.
9
Self-Reported Symptoms of Parkinson's Disease by Sex and Disease Duration.按性别和病程自我报告的帕金森病症状
West J Nurs Res. 2017 Nov;39(11):1412-1428. doi: 10.1177/0193945916670904. Epub 2016 Sep 23.
10
Motor symptoms in Parkinson's disease: A unified framework.帕金森病的运动症状:一个统一的框架。
Neurosci Biobehav Rev. 2016 Sep;68:727-740. doi: 10.1016/j.neubiorev.2016.07.010. Epub 2016 Jul 12.